The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Chatterjee, Sukanta ^a   Rego, Sylvan J ^b   D'Souza, Fulton ^b   Bhatia, B D ^c   Collard, Alix ^d,e   Datta, Sanjoy K ^d,e   Jacquet, Jeanne Marie ^d,e  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^c BANARAS HINDU UNIVERSITY   (India)

^d GlaxoSmithKline Pharmaceuticals Ltd   (India)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B ANTIBODY; POLYRIBOSYLRIBITOL PHOSPHATE; TETANUS ANTIBODY; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; DTWP HEPB HIB VACCINE; DTWP-HEPB-HIB VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; VIRUS ANTIBODY;

ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DROWSINESS; DRUG DOSAGE FORM COMPARISON; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HAEMOPHILUS INFECTION; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INDIA; INFANT; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE REDNESS; INJECTION SITE SWELLING; IRRITABILITY; MALE; NORMAL HUMAN; PERTUSSIS; PHASE 3 CLINICAL TRIAL; PREVENTIVE HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TETANUS; TREATMENT OUTCOME; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG TOXICITY; HYPEREMIA; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; PAIN; PATHOLOGY; SKIN DISEASE; SLEEP STAGE; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG TOXICITY; FEMALE; FEVER; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; HYPEREMIA; IMMUNIZATION SCHEDULE; INFANT; MALE; PAIN; SKIN DISEASES; SLEEP STAGES; VACCINATION;

EID: 77957917982     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-298     Document Type: Article

References (27)

1. Decker MD. Principles of pediatric combination vaccines and practical issues related to clinical practice. Pediatr Infect Dis J 2001, 20(11 Suppl):S10-18.
2. Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006, 25:507-12. 10.1097/01.inf.0000222413.47344.23, 16732148.
3. World Health Organization and UNICEF Global immunization coverage. 2009, Last accessed April 1st 2009, World Health Organization and UNICEF., http://www.who.int/immunization/newsroom/GID_english.pdf
4. Chunsuttiwat S, Biggs BA, Maynard JE, Thammapormpilas P, O-Prasertsawat M. Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand. Vaccine 2002, 21:188-93. 10.1016/S0264-410X(02)00461-9, 12450693.
5. Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003, 7:143-51. 10.1016/S1201-9712(03)90011-7, 12839717.
6. Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth. Human Vaccines 2005, 1:198-203.
7. Lagos R, Valenzuela MT, Levine OS, Losonsky GA, Erazo A, Wasserman SS, Levine MM. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998, 351(9114):1472-6. 10.1016/S0140-6736(97)07456-4, 9605803.
8. ICMR Indian Council of Medical Research guidelines governing clinical trials. 2006, ICMR., http://icmr.nic.in/ethical_guidelines.pdf
9. World Health Organization Immunization Policy. Global Programme for Vaccines and Immunization, Expanded Programme on Immunization. 1996, WHO/EPI/GEN/95.03REV.1, World Health Organization.
10. World Health Organization Introduction of hepatitis B vaccine into childhood immunization services. 2001, Last accessed 1st April 2009, World Health Organization., http://www.who.int/immunization_delivery/publications/HepB-MG_English.pdf
11. World Health Organization WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006, 81(47):445-52. World Health Organization.
12. Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, Russell A. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007, 26(6):496-500. 10.1097/INF.0b013e31805d7f17, 17529866.
13. Prymula R, Plisek S. Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines. Exp Opin Biol Ther 2008, 8(4):503-13.
14. Bavdekar SB, Maiya PP, Subba Rao SD, Datta SK, Bock HL. Immunogenicity and safety of combined diphtheria-tetanus-whole cell pertussis-hepatitis B/Haemophilus influenzae type b vaccine in Indian infants previously primed at birth with hepatitis B vaccination. Indian Pediatrics 2007, 44(7):505-10.
15. Bravo L, Carlos J, Gatchalian S, Borja-Tabora C, Bibera G, Willems P, Safary A, Bock HL. The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J Trop Med Public Health 1998, 29:772-8.
16. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type b vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Pediatr Infect Dis J 2006, 25:706-12. 10.1097/01.inf.0000223488.80814.df, 16874170.
17. World Health Organisation Immunization Standards. Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b (1 dose vial). Last accessed 12th July 2010., World Health Organisation., http://www.who.int/immunization_standards/vaccine_quality/56_diphteta/en/index.html
18. World Health Organisation Immunization Standards. Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b (1 dose vial). Last accessed 12th July 2010., World Health Organisation., http://www.who.int/immunization_standards/vaccine_quality/59_diphteta/en/index.html
19. Espinoza F, Tregnaghi M, Gentile A, Abarca K, Casellas J, Collard A, Lefevre I, Jacquet J-M. Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial. BMC Infect Dis 2010,
20. Fernandez J, Balter S, Feris J, Gomez E, Garib Z, Castellanos PL, Sánchez J, Romero-Steiner S, Levine OS. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 2000, 62:485-90.
21. Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol 2001, 8:1115-9. 96235, 11687449.
22. Campbell JD, Lagos R, Levine MM, Losonosky GA. Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants. Pediatr Infect Dis J 2002, 21:822-6. 10.1097/00006454-200209000-00007, 12352802.
23. Huebner RE, Nicol M, Mothupi R, Kayhty H, Mbelle N, Khomo E, Klugman KP. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Vaccine 2004, 23:802-6. 10.1016/j.vaccine.2004.06.052, 15542205.
24. Nicol M, Huebner R, Mothupi R, Käyhty H, Mbelle N, Khomo E. Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial. Paediatr Infect Dis J 2002, 21:138-41.
25. Tregnaghi M, Lopez P, Rocha C, Rivera L, David MP, Ruttimann R, Schuerman L. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006, 19:179-88. 10.1590/S1020-49892006000300006, 16640847.
26. Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, Lefevre I. A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life. Human Vaccines 2008, 4(1):60-6.
27. Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, Viviani S. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vacc 2006, 2(4):155-60.